National Meetings

For every guideline it develops, SIGN holds a national open meeting to give the guideline development group the opportunity to present its preliminary conclusions and draft recommendations to a wider audience.

Participants are able to contribute to and influence the form of the final guideline. Often the guideline development group obtains valuable feedback, such as suggestions for additional evidence it might consider, or an alternative interpretation of the evidence.

SIGN Guideline on Migraine: Pharmacological management

National open consultation meeting
10am-1.00pm, Thursday 15th June 2017
Royal College of Physicians, 9 Queen St, Edinburgh EH2 1JQ

The Scottish Intercollegiate Guidelines Network (SIGN) is producing a new guideline on the pharmacological management of patients with migraine, due for publication in early 2018. The draft guideline considers the evidence for acute and preventive pharmacological therapies for patients with migraine, along with devices therapies.

The guideline recommendations are based on a systematic review of evidence and have been developed by a multidisciplinary group with representation from across NHSScotland.

The SIGN guideline development group needs your feedback on the content and draft recommendations to ensure they are relevant and implementable in your area. This consultation meeting will provide an overview and an opportunity for discussion of the draft guideline, including:

The open meeting will be of interest to healthcare professionals in primary and secondary care who manage patients with migraine, pharmacists, patients and carers.

SIGN Guideline on Migraine: Pharmacological management
National open consultation meeting programme PDF

To register for this meeting please go to . For further information please contact Euan Bremner, 0131 623 4729

l Meetings

There are no National Meetings scheduled at present.

Events <Home